← Leaderboards
Dennis F. Deen
University Of California San Francisco
$1,495,650
Attributed
$1,495,650
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,495,650 · 1
By mechanism
R01$1,495,650 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Sarah J. Nelson$26,058,232
- Katherine Kurshan Matthay$7,757,759
- Francis C Szoka$17,593,815
- Yuet W Kan$9,706,494
- Joel Palefsky$28,104,336
Others in their field
Top investigators on “Neoplasm /Cancer Radiation Therapy”
- Charles A Coltman · Southwest Oncology Group$65,101,418
- Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
- Philip J Disaia · University Of California Irvine$47,533,330
- Walter J Curran · Thomas Jefferson University$41,640,321
- Samuel A Wells · Duke University$32,148,803
- John H. Glick · University Of Pennsylvania$26,662,963
Research focus
Neoplasm /Cancer Radiation TherapyBax Gene /ProteinTransfection /Expression VectorNeoplasm /Cancer GeneticsGene TherapyGliomaHuman SubjectHypoxiaImmunocytochemistryLaboratory RatNonhuman Therapy EvaluationRadiation GeneticsRecombinant VirusTranscription FactorAdeno Associated Virus GroupWestern BlottingsAminohydrolasesClinical ResearchCombination Cancer Therapy
Grant awards (5)
GENE THERAPY TARGETING HYPOXIC GLIOMA CELLS$311,594
R01 · FY2005 · CA
GENE THERAPY TARGETING HYPOXIC GLIOMA CELLS$311,594
R01 · FY2004 · CA
GENE THERAPY TARGETING HYPOXIC GLIOMA CELLS$311,594
R01 · FY2003 · CA
GENE THERAPY TARGETING HYPOXIC GLIOMA CELLS$280,434
R01 · FY2002 · CA
GENE THERAPY TARGETING HYPOXIC GLIOMA CELLS$280,434
R01 · FY2001 · CA